Covid-19 Impact on Coagulation Factor IX Market , Global Research Reports 2020-2021

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Coagulation Factor IX Industry

1.7 COVID-19 Impact: Coagulation Factor IX Market Trends

2 Global Coagulation Factor IX Quarterly Market Size Analysis

2.1 Coagulation Factor IX Business Impact Assessment - COVID-19

2.1.1 Global Coagulation Factor IX Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Coagulation Factor IX Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Coagulation Factor IX Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Coagulation Factor IX Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Coagulation Factor IX Factory Price by Manufacturers

3.3 Location of Key Manufacturers Coagulation Factor IX Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Coagulation Factor IX Market

3.5 Key Manufacturers Coagulation Factor IX Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Coagulation Factor IX Segments, By Type

4.1 Introduction

1.4.1 Coagulation Factor IX (Plasma Derived)

1.4.2 Coagulation Factor IX (Recombinant)

4.2 By Type, Global Coagulation Factor IX Market Size, 2019-2021

4.2.1 By Type, Global Coagulation Factor IX Market Size by Type, 2020-2021

4.2.2 By Type, Global Coagulation Factor IX Price, 2020-2021

5 Impact of Covid-19 on Coagulation Factor IX Segments, By Application

5.1 Overview

5.5.1 Adult

5.5.2 Kids

5.2 By Application, Global Coagulation Factor IX Market Size, 2019-2021

5.2.1 By Application, Global Coagulation Factor IX Market Size by Application, 2019-2021

5.2.2 By Application, Global Coagulation Factor IX Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 Pfizer

7.1.1 Pfizer Business Overview

7.1.2 Pfizer Coagulation Factor IX Quarterly Production and Revenue, 2020

7.1.3 Pfizer Coagulation Factor IX Product Introduction

7.1.4 Pfizer Response to COVID-19 and Related Developments

7.2 CSL Behring

7.2.1 CSL Behring Business Overview

7.2.2 CSL Behring Coagulation Factor IX Quarterly Production and Revenue, 2020

7.2.3 CSL Behring Coagulation Factor IX Product Introduction

7.2.4 CSL Behring Response to COVID-19 and Related Developments

7.3 Grifols

7.3.1 Grifols Business Overview

7.3.2 Grifols Coagulation Factor IX Quarterly Production and Revenue, 2020

7.3.3 Grifols Coagulation Factor IX Product Introduction

7.3.4 Grifols Response to COVID-19 and Related Developments

7.4 Novo Nordisk

7.4.1 Novo Nordisk Business Overview

7.4.2 Novo Nordisk Coagulation Factor IX Quarterly Production and Revenue, 2020

7.4.3 Novo Nordisk Coagulation Factor IX Product Introduction

7.4.4 Novo Nordisk Response to COVID-19 and Related Developments

7.5 Bioverativ

7.5.1 Bioverativ Business Overview

7.5.2 Bioverativ Coagulation Factor IX Quarterly Production and Revenue, 2020

7.5.3 Bioverativ Coagulation Factor IX Product Introduction

7.5.4 Bioverativ Response to COVID-19 and Related Developments

7.6 Sanquin

7.6.1 Sanquin Business Overview

7.6.2 Sanquin Coagulation Factor IX Quarterly Production and Revenue, 2020

7.6.3 Sanquin Coagulation Factor IX Product Introduction

7.6.4 Sanquin Response to COVID-19 and Related Developments

7.7 Takeda

7.7.1 Takeda Business Overview

7.7.2 Takeda Coagulation Factor IX Quarterly Production and Revenue, 2020

7.7.3 Takeda Coagulation Factor IX Product Introduction

7.7.4 Takeda Response to COVID-19 and Related Developments

7.8 Baxter

7.8.1 Baxter Business Overview

7.8.2 Baxter Coagulation Factor IX Quarterly Production and Revenue, 2020

7.8.3 Baxter Coagulation Factor IX Product Introduction

7.8.4 Baxter Response to COVID-19 and Related Developments

7.9 Aptevo

7.9.1 Aptevo Business Overview

7.9.2 Aptevo Coagulation Factor IX Quarterly Production and Revenue, 2020

7.9.3 Aptevo Coagulation Factor IX Product Introduction

7.9.4 Aptevo Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Coagulation Factor IX Supply Chain Analysis

8.1.1 Coagulation Factor IX Supply Chain Analysis

8.1.2 Covid-19 Impact on Coagulation Factor IX Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Coagulation Factor IX Distribution Channels

8.2.2 Covid-19 Impact on Coagulation Factor IX Distribution Channels

8.2.3 Coagulation Factor IX Distributors

8.3 Coagulation Factor IX Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Coagulation Factor IX Assessment

Table 9. COVID-19 Impact: Coagulation Factor IX Market Trends

Table 10. COVID-19 Impact Global Coagulation Factor IX Market Size

Table 11. Global Coagulation Factor IX Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

Table 12. Global Coagulation Factor IX Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

Table 13. Global Coagulation Factor IX Quarterly Market Size, 2020 (US$ Million) & (K Units)

Table 14. Global Coagulation Factor IX Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Coagulation Factor IX Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

Table 16. Global Coagulation Factor IX Market Growth Drivers

Table 17. Global Coagulation Factor IX Market Restraints

Table 18. Global Coagulation Factor IX Market Opportunities

Table 19. Global Coagulation Factor IX Market Challenges

Table 20. Key Manufacturers Coagulation Factor IX Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Coagulation Factor IX Market Size, 2019 (K Units) & (US$ Million)

Table 22. Coagulation Factor IX Factory Price by Manufacturers 2020 (USD/Unit)

Table 23. Location of Key Manufacturers Coagulation Factor IX Manufacturing Plants

Table 24. Key Manufacturers Coagulation Factor IX Market Served

Table 25. Date of Key Manufacturers Enter into Coagulation Factor IX Market

Table 26. Key Manufacturers Coagulation Factor IX Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Coagulation Factor IX Market Size by Type, 2020, (US$ Million)

Table 29. Global Coagulation Factor IX Market Size by Type, 2020 (K Units)

Table 30. Global Coagulation Factor IX Price: by Type, 2020-2021 (USD/Unit)

Table 31. Global Coagulation Factor IX Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Coagulation Factor IX Market Size by Application, 2020-2021 (K Units)

Table 33. Global Coagulation Factor IX Price: by Application, 2020-2021 (USD/Unit)

Table 34. Global Coagulation Factor IX Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Coagulation Factor IX Market Size by Region, 2019-2021 (K Units)

Table 36. By Country, North America Coagulation Factor IX Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Coagulation Factor IX Market Size, 2019-2021 (K Units)

Table 38. US Coagulation Factor IX Market Size, 2019-2021 (US$ Million) & (K Units)

Table 39. Canada Coagulation Factor IX Market Size, 2019-2021 (US$ Million) & (K Units)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Coagulation Factor IX Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Coagulation Factor IX Market Size, 2019-2021 (K Units)

Table 43. Germany Coagulation Factor IX Market Size, 2019-2021 (US$ Million) & (K Units)

Table 44. France Coagulation Factor IX Market Size, 2019-2021 (US$ Million) & (K Units)

Table 45. UK Coagulation Factor IX Market Size, 2019-2021 (US$ Million) & (K Units)

Table 46. Italy Coagulation Factor IX Market Size, 2019-2021 (US$ Million) & (K Units)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Coagulation Factor IX Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Coagulation Factor IX Market Size, 2019-2021 (K Units)

Table 50. China Coagulation Factor IX Market Size, 2019-2021 (US$ Million) & (K Units)

Table 51. Japan Coagulation Factor IX Market Size, 2019-2021 (US$ Million) & (K Units)

Table 52. South Korea Coagulation Factor IX Market Size, 2019-2021 (US$ Million) & (K Units)

Table 53. India Coagulation Factor IX Market Size, 2019-2021 (US$ Million) & (K Units)

Table 54. ASEAN Coagulation Factor IX Market Size, 2019-2021 (US$ Million) & (K Units)

Table 55. Latin America Coagulation Factor IX Market Size, 2019-2021 (US$ Million) & (K Units)

Table 56. Middle East and Africa Coagulation Factor IX Market Size, 2019-2021 (US$ Million) & (K Units)

Table 57. Pfizer Business Overview

Table 58. Pfizer Coagulation Factor IX Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Pfizer Coagulation Factor IX Product

Table 60. Pfizer Response to COVID-19 and Related Developments

Table 61. CSL Behring Business Overview

Table 62. CSL Behring Coagulation Factor IX Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. CSL Behring Coagulation Factor IX Product

Table 64. CSL Behring Response to COVID-19 and Related Developments

Table 65. Grifols Business Overview

Table 66. Grifols Coagulation Factor IX Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Grifols Coagulation Factor IX Product

Table 68. Grifols Response to COVID-19 and Related Developments

Table 69. Novo Nordisk Business Overview

Table 70. Novo Nordisk Coagulation Factor IX Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Novo Nordisk Coagulation Factor IX Product

Table 72. Novo Nordisk Response to COVID-19 and Related Developments

Table 73. Bioverativ Business Overview

Table 74. Bioverativ Coagulation Factor IX Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Bioverativ Coagulation Factor IX Product

Table 76. Bioverativ Response to COVID-19 and Related Developments

Table 77. Sanquin Business Overview

Table 78. Sanquin Coagulation Factor IX Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Sanquin Coagulation Factor IX Product

Table 80. Sanquin Response to COVID-19 and Related Developments

Table 81. Takeda Business Overview

Table 82. Takeda Coagulation Factor IX Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Takeda Coagulation Factor IX Product

Table 84. Takeda Response to COVID-19 and Related Developments

Table 85. Baxter Business Overview

Table 86. Baxter Coagulation Factor IX Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Baxter Coagulation Factor IX Product

Table 88. Baxter Response to COVID-19 and Related Developments

Table 89. Aptevo Business Overview

Table 90. Aptevo Coagulation Factor IX Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Aptevo Coagulation Factor IX Product

Table 92. Aptevo Response to COVID-19 and Related Developments

Table 93. Coagulation Factor IX Distributors List

Table 94. Coagulation Factor IX Customers List

Table 95. Covid-19 Impact on Coagulation Factor IX Customers

List of Figures

Figure 1. Coagulation Factor IX Product Picture

Figure 2. Coagulation Factor IX Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Coagulation Factor IX Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Coagulation Factor IX Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Coagulation Factor IX Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Coagulation Factor IX Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Coagulation Factor IX Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Coagulation Factor IX Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Coagulation Factor IX Market Size Market Share, 2019-2021